MedTrace Logo

Ripple Mapping Guided Ablation of Ischaemic Ventricular Tachycardia.

NCT03997201 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-07-21

No results posted yet for this study

Summary

The Ripple VT-1 Study is a prospective clinical trial that aims to investigate if catheter ablation of ventricular tachycardia in patients with ischaemic heart disease can be effectively performed using Ripple Mapping.

Conditions

  • Ventricular Tachycardia
  • Ischemic Heart Disease

Interventions

PROCEDURE

Ripple Mapping guided ischaemic VT ablation

Endocardial mapping of the ventricle performed with Ripple Mapping (CARTO3v6, Biosense Webster Inc). Ablation (SmarTouch Thermocool Catheter, Biosense Webster Inc) delivered to areas of abnormal "late" electrical activity within ventricular scar tissue.

Sponsors & Collaborators

  • Barts & The London NHS Trust

    collaborator OTHER

  • Papworth Hospital NHS Foundation Trust

    collaborator OTHER_GOV

  • Nottingham University Hospitals NHS Trust

    collaborator OTHER

  • Newcastle-upon-Tyne Hospitals NHS Trust

    collaborator OTHER

  • Hospital de Santa Maria, Portugal

    collaborator OTHER

  • Imperial College Healthcare NHS Trust

    lead OTHER

Principal Investigators

  • Prapa Kanagaratnam · Imperial College Healthcare NHS Trust

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-18
Primary Completion
2022-04-30
Completion
2022-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03997201 on ClinicalTrials.gov